Close

ENZN Financial Facts

Basic (in Dollars per share): -0.19
Total other expense: -1.14M
See Full Income Statement

Other assets: 565K
Accumulated deficit: -140.04M
See Full Balance Sheet

Enzon Pharmaceuticals Inc. (ENZN) Earnings

  |   Expand Research on ENZN
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate 0.0% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -4.4% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/10/22 Q222 N/AN/A N/A N/AN/A N/A N/A N/A
3/18/13 Q412 -$0.11N/A N/A $10.65M$10.01M N/A Details
10/31/12 Q312 $0.08N/A N/A N/AN/A N/A Details
8/1/12 Q212 -$0.02N/A N/A $9.8M$9.2M N/A Details
5/2/12 Q112 -$0.02N/A N/A $10.6M$18.02M N/A Details
3/12/12 Q411 -$0.10N/A N/A $9.8M$10.6M N/A Details
11/30/-1 Q311 -$0.19N/A N/A $10.44M$13.23M N/A Details
8/4/11 Q211 -$0.13$0.00 -$0.13$9.6M$15.47M N/A Details